These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33678581)

  • 1. Survival prediction after upfront surgery in patients with pancreatic ductal adenocarcinoma: Radiomic, clinic-pathologic and body composition analysis.
    Shi H; Wei Y; Cheng S; Lu Z; Zhang K; Jiang K; Xu Q
    Pancreatology; 2021 Jun; 21(4):731-737. PubMed ID: 33678581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative evaluating early recurrence in resectable pancreatic ductal adenocarcinoma by using CT radiomics.
    Wang G; Lei W; Duan S; Cao A; Shi H
    Abdom Radiol (NY); 2024 Feb; 49(2):484-491. PubMed ID: 37955726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
    Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
    Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma.
    Park S; Sham JG; Kawamoto S; Blair AB; Rozich N; Fouladi DF; Shayesteh S; Hruban RH; He J; Wolfgang CL; Yuille AL; Fishman EK; Chu LC
    AJR Am J Roentgenol; 2021 Nov; 217(5):1104-1112. PubMed ID: 34467768
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenocarcinoma patients.
    Wang F; Zhao Y; Xu J; Shao S; Yu D
    Front Oncol; 2022; 12():1037672. PubMed ID: 36518321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
    Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
    Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.
    Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z
    Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study.
    Liang L; Ding Y; Yu Y; Liu K; Rao S; Ge Y; Zeng M
    BMC Med Imaging; 2021 Apr; 21(1):75. PubMed ID: 33902469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis.
    Ye Y; Zhang J; Song P; Qin P; Hu Y; An P; Li X; Lin Y; Wang J; Feng G
    Technol Cancer Res Treat; 2023; 22():15330338231180792. PubMed ID: 37287274
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study.
    Li K; Yao Q; Xiao J; Li M; Yang J; Hou W; Du M; Chen K; Qu Y; Li L; Li J; Wang X; Luo H; Yang J; Zhang Z; Chen W
    Cancer Imaging; 2020 Jan; 20(1):12. PubMed ID: 32000852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
    Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
    World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma.
    Meng Y; Yu J; Zhu M; Zhou J; Li N; Liu F; Zhang H; Fang X; Li J; Feng X; Wang L; Jiang H; Lu J; Shao C; Bian Y
    Abdom Radiol (NY); 2022 Aug; 47(8):2822-2834. PubMed ID: 35451626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
    Zeng P; Qu C; Liu J; Cui J; Liu X; Xiu D; Yuan H
    Acta Radiol; 2023 Jul; 64(7):2221-2228. PubMed ID: 36474439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed Tomography-based Radiomics Evaluation of Postoperative Local Recurrence of Pancreatic Ductal Adenocarcinoma.
    He M; Chen X; Wels M; Lades F; Li Y; Liu Z; Jin Z; Xue H
    Acad Radiol; 2023 Apr; 30(4):680-688. PubMed ID: 35906151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients.
    Wang K; Karalis JD; Elamir A; Bifolco A; Wachsmann M; Capretti G; Spaggiari P; Enrico S; Balasubramanian K; Fatimah N; Pontecorvi G; Nebbia M; Yopp A; Kaza R; Pedrosa I; Zeh H; Polanco P; Zerbi A; Wang J; Aguilera T; Ligorio M
    Ann Surg Oncol; 2024 Apr; 31(4):2608-2620. PubMed ID: 38151623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying radiomics signatures in body composition imaging for the prediction of outcome following pancreatic cancer resection.
    van der Kroft G; Wee L; Rensen SS; Brecheisen R; van Dijk DPJ; Eickhoff R; Roeth AA; Ulmer FT; Dekker A; Neumann UP; Olde Damink SWM
    Front Oncol; 2023; 13():1062937. PubMed ID: 37637046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
    Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
    Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of 18 F-FDG PET/CT Radiomics in Patients With Resectable Pancreatic Ductal Adenocarcinoma Undergoing Curative Surgery.
    Yoo J; Hyun SH; Lee J; Cheon M; Lee KH; Heo JS; Choi JY
    Clin Nucl Med; 2024 Oct; 49(10):909-916. PubMed ID: 38968550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and multicenter validation of a CT-based radiomics signature for discriminating histological grades of pancreatic ductal adenocarcinoma.
    Chang N; Cui L; Luo Y; Chang Z; Yu B; Liu Z
    Quant Imaging Med Surg; 2020 Mar; 10(3):692-702. PubMed ID: 32269929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics model-based algorithm for preoperative prediction of pancreatic ductal adenocarcinoma grade.
    Tikhonova VS; Karmazanovsky GG; Kondratyev EV; Gruzdev IS; Mikhaylyuk KA; Sinelnikov MY; Revishvili AS
    Eur Radiol; 2023 Feb; 33(2):1152-1161. PubMed ID: 35986774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.